Certificate of analysis · Apex Laboratory
Cerebrolysin 60 mg
APX-2026-0627-C
View Cerebrolysin 60 mg product
For laboratory research use only. The issue date identifies this certificate; it is not a testing date.
Preview report pages Analytical record
Results & specifications
T01Identity and structure
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Orthogonal identity against specified reference60 mg porcine brain-protein enzymatic hydrolysate reference mixture. mass basis is total amino-acid residue equivalent; define48.0 mg free amino acids and 12.0 mg peptides per vial for fingerprint exercises. No single active sequence. | Conforms to the assigned reference; see identity basisPASS | Conforms to the specified acceptance criterion | M-T01-DEFAULT |
Supporting analytical detail for Orthogonal identity against specified reference
| |||
| Orthogonal fingerprint similarityspectrum/peptide-map comparison; score is not proof of stereochemistry | 0.9994 similarity (0-1)PASS | >= 0.995similarity (0-1) | M-T01-DEFAULT |
Supporting analytical detail for Orthogonal fingerprint similarity
| |||
T02Chromatographic purity
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Multipeak fingerprint similarity to defined referenceFingerprint similarity, not chemical purity percentage | 0.9996 similarity (0-1)PASS | >= 0.995similarity (0-1) | M-T02-DEFAULT |
Supporting analytical detail for Multipeak fingerprint similarity to defined reference
| |||
T05Related substances and degradants
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| New unexplained chromatographic signal outside defined fingerprintAggregate non-reference signal; not mass fraction or component purity | 0.035 % total fingerprint responsePASS | <= 0.1% total fingerprint response | M-T05-DEFAULT |
Supporting analytical detail for New unexplained chromatographic signal outside defined fingerprint
| |||
T03Active content and assay
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Cerebrolysin 60 mg active contentAssigned component material basis; excludes vehicle/excipient/water; salt basis explicitly in identity specification | 60.1572 mg/vialPASS | 58.8 to 61.2mg/vial | M-T03-DEFAULT |
Supporting analytical detail for Cerebrolysin 60 mg active content
| |||
| Cerebrolysin 60 mg label claim assayIndependent calibrated amount / nominal amount x 100; not chromatographic area purity | 100.262 % label claimPASS | 98 to 102% label claim | M-T03-DEFAULT |
Supporting analytical detail for Cerebrolysin 60 mg label claim assay
| |||
T15Unit uniformity
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Cerebrolysin 60 mg individual-unit meanspecified sample/form only | 100.262 % label claimPASS | 98 to 102% label claim | M-T15-DEFAULT |
Supporting analytical detail for Cerebrolysin 60 mg individual-unit mean
| |||
| Cerebrolysin 60 mg acceptance value (n=10)AV=abs(M-mean)+2.4 sample SD; target 100%; M=mean within 98.5-101.5 | 0.8458 % label claimPASS | <= 15% label claim | M-T15-DEFAULT |
Supporting analytical detail for Cerebrolysin 60 mg acceptance value (n=10)
| |||
| Cerebrolysin 60 mg individual-unit RSDPrecision criterion for the listed specification, independently of AV | 0.3515 %PASS | <= 2% | M-T15-DEFAULT |
Supporting analytical detail for Cerebrolysin 60 mg individual-unit RSD
| |||
T04Blend composition
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Applicability decisionspecified sample/form only | Not applicable — One declared active or a water/preservative reagent. Preservative is separately quantified under T14; there is no multi-active blend ratio.N/A — justified | Not applicable — One declared active or a water/preservative reagent. Preservative is separately quantified under T14; there is no multi-active blend ratio. | M-T04-DEFAULT |
Supporting analytical detail for Applicability decision
| |||
T06Water content
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Residual waterWater as percentage of total net formulation, not peptide area purity | 0.49 % w/w finished fillPASS | <= 2% w/w finished fill | M-T06-KF |
Supporting analytical detail for Residual water
| |||
T07Counterions and associated species
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Acetate content relative to parent active massExplicit process/counterion basis; acetate-associated material. No fixed stoichiometric salt is asserted; acidic peptides may contain residual process acetate rather than a counterion. | 1.5 % acetate/parent massPASS | 0.5 to 3% acetate/parent mass | M-T07-DEFAULT |
Supporting analytical detail for Acetate content relative to parent active mass
| |||
T08Residual solvents
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| MethanolMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 21.113 ug/g finished fillPASS | <= 3000ug/g finished fill | M-T08-DEFAULT |
Supporting analytical detail for Methanol
| |||
| AcetonitrileMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 8.872 ug/g finished fillPASS | <= 410ug/g finished fill | M-T08-DEFAULT |
Supporting analytical detail for Acetonitrile
| |||
| DichloromethaneMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 3.812 ug/g finished fillPASS | <= 600ug/g finished fill | M-T08-DEFAULT |
Supporting analytical detail for Dichloromethane
| |||
| N, N-dimethylformamideMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 4.375 ug/g finished fillPASS | <= 880ug/g finished fill | M-T08-DEFAULT |
Supporting analytical detail for N, N-dimethylformamide
| |||
| EthanolMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 34.306 ug/g finished fillPASS | <= 5000ug/g finished fill | M-T08-DEFAULT |
Supporting analytical detail for Ethanol
| |||
| AcetoneMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 11.108 ug/g finished fillPASS | <= 5000ug/g finished fill | M-T08-DEFAULT |
Supporting analytical detail for Acetone
| |||
| Ethyl acetateMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 8.292 ug/g finished fillPASS | <= 5000ug/g finished fill | M-T08-DEFAULT |
Supporting analytical detail for Ethyl acetate
| |||
| TolueneMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 1.867 ug/g finished fillPASS | <= 890ug/g finished fill | M-T08-DEFAULT |
Supporting analytical detail for Toluene
| |||
| n-HexaneMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 1.096 ug/g finished fillPASS | <= 290ug/g finished fill | M-T08-DEFAULT |
Supporting analytical detail for n-Hexane
| |||
| BenzeneMaterial-based limit. Liquid numerical limits are listed specification and not ICH Option1 mass ppm. | 0.076 ug/g finished fillPASS | <= 2ug/g finished fill | M-T08-DEFAULT |
Supporting analytical detail for Benzene
| |||
T09Elemental impurities
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| LeadTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0123 ug/g finished fillPASS | <= 0.5ug/g finished fill | M-T09-DEFAULT |
Supporting analytical detail for Lead
| |||
| CadmiumTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0084 ug/g finished fillPASS | <= 0.2ug/g finished fill | M-T09-DEFAULT |
Supporting analytical detail for Cadmium
| |||
| ArsenicTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0186 ug/g finished fillPASS | <= 0.5ug/g finished fill | M-T09-DEFAULT |
Supporting analytical detail for Arsenic
| |||
| MercuryTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0061 ug/g finished fillPASS | <= 0.1ug/g finished fill | M-T09-DEFAULT |
Supporting analytical detail for Mercury
| |||
| CobaltTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0205 ug/g finished fillPASS | <= 1ug/g finished fill | M-T09-DEFAULT |
Supporting analytical detail for Cobalt
| |||
| VanadiumTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0254 ug/g finished fillPASS | <= 1ug/g finished fill | M-T09-DEFAULT |
Supporting analytical detail for Vanadium
| |||
| NickelTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0326 ug/g finished fillPASS | <= 2ug/g finished fill | M-T09-DEFAULT |
Supporting analytical detail for Nickel
| |||
| PalladiumTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.01 ug/g finished fillPASS | <= 1ug/g finished fill | M-T09-DEFAULT |
Supporting analytical detail for Palladium
| |||
| PlatinumTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0091 ug/g finished fillPASS | <= 1ug/g finished fill | M-T09-DEFAULT |
Supporting analytical detail for Platinum
| |||
| RhodiumTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.007 ug/g finished fillPASS | <= 1ug/g finished fill | M-T09-DEFAULT |
Supporting analytical detail for Rhodium
| |||
| RutheniumTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0083 ug/g finished fillPASS | <= 1ug/g finished fill | M-T09-DEFAULT |
Supporting analytical detail for Ruthenium
| |||
| IridiumTotal element; no speciation. material-based criterion, not a dose/route-derived safety limit. | 0.0056 ug/g finished fillPASS | <= 1ug/g finished fill | M-T09-DEFAULT |
Supporting analytical detail for Iridium
| |||
T13pH and analytical solution
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| pH of specified buffered analytical solution1.000 mg active/mL in 25mM acetate buffer, pH4.80,25.0C; buffer-solution compatibility is not the pH of dry material | 4.77 pHPASS | 4.1 to 5.5pH | M-T13-DEFAULT |
Supporting analytical detail for pH of specified buffered analytical solution
| |||
T14Excipients and preservatives
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Trehalose contentSeparate excipient-specific assay; not label active | 5.004 mg/vialPASS | 4.75 to 5.25mg/vial | M-T14-DEFAULT |
Supporting analytical detail for Trehalose content
| |||
T21Appearance and physical inspection
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| AppearanceThree containers under diffuse white illumination | white to off-white; uniform lyophilized cakePASS | Conforms to the specified acceptance criterion | M-T21-DEFAULT |
Supporting analytical detail for Appearance
| |||
| Visible foreign matterVisual observation only; subvisible particles reported separately | None observed in 3 inspected unitsPASS | Conforms to the specified acceptance criterion | M-T21-DEFAULT |
Supporting analytical detail for Visible foreign matter
| |||
T10Sterility test
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Sterility: FTMFTM30-35C; tested units only; growth-promotion/suitability controls conform | No growth at 14 days in all 20 unitsPASS | Conforms to the specified acceptance criterion | M-T10-DEFAULT |
Supporting analytical detail for Sterility: FTM
| |||
| Sterility: SCDMSCDM20-25C; tested units only; no sterility assurance level assigned | No growth at 14 days in all 20 unitsPASS | Conforms to the specified acceptance criterion | M-T10-DEFAULT |
Supporting analytical detail for Sterility: SCDM
| |||
T11Bacterial endotoxins
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Bacterial endotoxinsSample reporting limit after1:5 dilution; threshold is and not based on administration route/dose | <0.025 EU/mg active-equivalentPASS | <= 0.1EU/mg active-equivalent | M-T11-DEFAULT |
Supporting analytical detail for Bacterial endotoxins
| |||
T12Microbial enumeration
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| TAMCZero colonies observed from1g or1 mL equivalent filter; report <1, not exact absence | <1 CFU/g finished fillPASS | <= 100CFU/g finished fill | M-T12-DEFAULT |
Supporting analytical detail for TAMC
| |||
| TYMCZero colonies observed from1g or1 mL equivalent filter; report <1, not exact absence | <1 CFU/g finished fillPASS | <= 10CFU/g finished fill | M-T12-DEFAULT |
Supporting analytical detail for TYMC
| |||
| Escherichia coliSpecified-organism enrichment in explicit1g/1 mL scope; not a universal pharmacopeial panel | Not detected in 1gPASS | Conforms to the specified acceptance criterion | M-T12-DEFAULT |
Supporting analytical detail for Escherichia coli
| |||
| Staphylococcus aureusSpecified-organism enrichment in explicit1g/1 mL scope; not a universal pharmacopeial panel | Not detected in 1gPASS | Conforms to the specified acceptance criterion | M-T12-DEFAULT |
Supporting analytical detail for Staphylococcus aureus
| |||
| Pseudomonas aeruginosaSpecified-organism enrichment in explicit1g/1 mL scope; not a universal pharmacopeial panel | Not detected in 1gPASS | Conforms to the specified acceptance criterion | M-T12-DEFAULT |
Supporting analytical detail for Pseudomonas aeruginosa
| |||
| Salmonella speciesSpecified-organism enrichment in explicit1g/1 mL scope; not a universal pharmacopeial panel | Not detected in 1gPASS | Conforms to the specified acceptance criterion | M-T12-DEFAULT |
Supporting analytical detail for Salmonella species
| |||
| Candida albicansSpecified-organism enrichment in explicit1g/1 mL scope; not a universal pharmacopeial panel | Not detected in 1gPASS | Conforms to the specified acceptance criterion | M-T12-DEFAULT |
Supporting analytical detail for Candida albicans
| |||
T16Biological activity
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Applicability decisionspecified sample/form only | Not applicable — No qualified, reference-traceable potency endpoint is established for this selected identity. Identity/content data cannot justify an invented biological potency value; exploratory biological activity would require a separately defined assay.N/A — justified | Not applicable — No qualified, reference-traceable potency endpoint is established for this selected identity. Identity/content data cannot justify an invented biological potency value; exploratory biological activity would require a separately defined assay. | M-T16-DEFAULT |
Supporting analytical detail for Applicability decision
| |||
T17Protein and conjugate characterization
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Size-exclusion main defined populationSame primary SEC population result as T02 for proteins; orthogonal size separation for PEG/mixtures. Includes expected biological heterogeneity. | 99.91 % SEC responsePASS | 99.7 to 100% SEC response | M-T17-DEFAULT |
Supporting analytical detail for Size-exclusion main defined population
| |||
| High molecular weight aggregate fractionspecified sample/form only | 0.045 % SEC responsePASS | <= 0.1% SEC response | M-T17-DEFAULT |
Supporting analytical detail for High molecular weight aggregate fraction
| |||
| Low molecular weight non-reference fractionspecified sample/form only | 0.045 % SEC responsePASS | <= 0.1% SEC response | M-T17-DEFAULT |
Supporting analytical detail for Low molecular weight non-reference fraction
| |||
| Orthogonal construct/fingerprint mappingIdentity Reference defines construct, termini, and mixture caveats; no raw mass spectrum or gel image exists | Conforms to explicit reference specificationPASS | Conforms to the specified acceptance criterion | M-T17-DEFAULT |
Supporting analytical detail for Orthogonal construct/fingerprint mapping
| |||
| Cerebrolysin Free amino-acid fraction80:20 specified reference partition; defined equivalent units avoid equating hydrolysis product molecular mass with original peptide mass | 48.1258 mg assigned residue equivalent/vialRecorded numeric value: 48.12575999998186PASS | 45.6 to 50.4Lower limit: 45.59999999999999Upper limit: 50.40000000000001mg assigned residue equivalent/vial | M-T17-HYDROLYSATE-AMINO-ACID-BALANCE |
Supporting analytical detail for Cerebrolysin Free amino-acid fraction
| |||
| Cerebrolysin Peptide-bound residue fraction80:20 specified reference partition; defined equivalent units avoid equating hydrolysis product molecular mass with original peptide mass | 12.0314 mg assigned residue equivalent/vialRecorded numeric value: 12.03143999999546PASS | 11.4 to 12.6mg assigned residue equivalent/vial | M-T17-HYDROLYSATE-AMINO-ACID-BALANCE |
Supporting analytical detail for Cerebrolysin Peptide-bound residue fraction
| |||
T18Process impurities
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Residual source-process protein impuritiesporcine tissue hydrolysate process; source-specific assay. For hydrolysates, intact source proteins outside the target digest are measured by selective separation; intended peptides are not HCP impurities. | 2.1 ng/mg assigned target materialPASS | <= 100ng/mg assigned target material | M-T18-DEFAULT |
Supporting analytical detail for Residual source-process protein impurities
| |||
| Residual source DNASource-specific qPCR in process; extraction recovery demonstrated only | 0.012 ng/vialPASS | <= 1ng/vial | M-T18-DEFAULT |
Supporting analytical detail for Residual source DNA
| |||
T19Particles and container closure
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Subvisible particles >= 10umAs-supplied liquid or entire dry vial dissolved to stated analytical volume; limits, no injectable compliance claim | 21 particles/containerPASS | <= 6000particles/container | M-T19-DEFAULT |
Supporting analytical detail for Subvisible particles >= 10um
| |||
| Subvisible particles >= 25umAs-supplied liquid or entire dry vial dissolved to stated analytical volume; limits, no injectable compliance claim | 2 particles/containerPASS | <= 600particles/container | M-T19-DEFAULT |
Supporting analytical detail for Subvisible particles >= 25um
| |||
| Vacuum decay package integritymethod vacuum-decay threshold0.20kPa/60s;5um positive defect control. No universal leakage-to-sterility equivalence. | 10/10test closures conform; positive-leak controls detectedPASS | Conforms to the specified acceptance criterion | M-T19-DEFAULT |
Supporting analytical detail for Vacuum decay package integrity
| |||
T20Stability observations
| Test / endpoint | Result | Acceptance criterion | Method |
|---|---|---|---|
| Reported 6 month assay retentionReported change relative to the initial assay. This report does not assign a retest date or shelf life. | 99.9102 % of initial assayPASS | 98 to 102% of initial assay | M-T20-DEFAULT |
Supporting analytical detail for Reported 6 month assay retention
| |||
| Dating dispositionReported change relative to the initial assay. This report does not assign a retest date or shelf life. | 6 month review point; actual expiry/retest not assignedPASS | Conforms to the specified acceptance criterion | M-T20-DEFAULT |
Supporting analytical detail for Dating disposition
| |||
Method references
How the results are documented
- M-T01-DEFAULT
- Orthogonal chemical/structural identityLC-HRMS/MS plus sequence/connectivity-sensitive reference comparison
- M-T02-DEFAULT
- Chromatographic purityRP-UPLC DAD; SEC for protein size species; HILIC/CAD for nonchromophoric analytes
- M-T05-DEFAULT
- Related substancesStability-indicating LC integration; orthogonal size/charge separation for biologics
- M-T03-DEFAULT
- Calibrated material contentIndependent quantitative LC/CAD, protein assay or bioactivity calibration for IU
- M-T15-DEFAULT
- Individual-unit uniformityTen separate unit preparations and fill measurements
- M-T04-DEFAULT
- Component-resolved blend assaySeparate calibrated selective assay for every declared component
- M-T06-KF
- Residual formulation water on a defined mass basisCoulometric Karl Fischer with oven transfer
- M-T07-DEFAULT
- Counterion compositionIon chromatography and stoichiometric accounting
- M-T08-DEFAULT
- Residual solvent panelheadspace GC-MS
- M-T09-DEFAULT
- Elemental impurity panelICP-MS
- M-T13-DEFAULT
- pH and solution stateCalibrated potentiometry
- M-T14-DEFAULT
- Excipients/preservativesComponent-specific quantitative LC/CAD or formulation identity
- M-T21-DEFAULT
- AppearanceControlled visual examination
- M-T10-DEFAULT
- Sterility observations in two media with matrix-specific preparationMembrane filtration/rinsing or neutralized direct inoculation for Lemon dispersion
- M-T11-DEFAULT
- Bacterial endotoxinsRecombinant factor C fluorometric assay
- M-T12-DEFAULT
- Microbial enumeration/organismsMembrane filtration enumeration and enrichment
- M-T16-DEFAULT
- Functional biological activityReference-relative concentration-response assay
- M-T17-DEFAULT
- Protein/conjugate characterizationSEC-MALS, CE-SDS, peptide mapping, glycan/PEG profiling
- M-T18-DEFAULT
- Biological process impurity panelHost/process-specific ELISA and qPCR
- M-T17-HYDROLYSATE-AMINO-ACID-BALANCE
- Cerebrolysin free and peptide-bound amino-acid equivalent balanceQuantitative amino-acid analysis before/after hydrolysis with calibrated difference
- M-T19-DEFAULT
- Particles and package integrityLight obscuration plus vacuum decay
- M-T20-DEFAULT
- Stability observationTime-zero/1/3/6-month trend
Apex Laboratory issues this certificate. Results apply to the stated configuration and lot. Browse all certificates.